Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Elisabeth Perez"'
Autor:
Maite Alvarez, Itziar Otano, Luna Minute, Maria Carmen Ochoa, Elisabeth Perez-Ruiz, Ignacio Melero, Pedro Berraondo
Publikováno v:
Cell Stress, Vol 3, Iss 7, Pp 236-239 (2019)
The TNF blockade therapy is currently a well-established treatment option for a variety of autoimmune diseases such as rheumatoid arthritis (RA), psoriasis or Crohn’s disease, given the proinflammatory role of TNF in the course of these diseases. I
Externí odkaz:
https://doaj.org/article/df119cc966a8481a88cd8ca42b49ab21
Autor:
Miguel-Angel Berciano-Guerrero, Mora Guardamagna, Elisabeth Perez-Ruiz, Jose-Miguel Jurado, Isabel Barragán, Antonio Rueda-Dominguez
Publikováno v:
Life, Vol 12, Iss 9, p 1302 (2022)
Metastatic melanoma (MM) is a pathological entity with a very poor prognosis that, until a few decades ago, had a low response rate to systemic treatments. Fortunately, in the last few years, new therapies for metastatic melanoma have emerged. Curren
Externí odkaz:
https://doaj.org/article/fbe0ab79699b4547b29a3613b3c82678
Autor:
Miguel-Angel Berciano-Guerrero, Rocío Lavado-Valenzuela, Aurelio Moya, Luis delaCruz-Merino, Fátima Toscano, Javier Valdivia, Victoria Castellón, Fernando Henao-Carrasco, Pilar Sancho, Juan-Luis Onieva-Zafra, Ismael Navas-Delgado, Antonio Rueda-Dominguez, Elisabeth Perez-Ruiz, Emilio Alba
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 284 (2022)
Targeted therapy in metastatic melanoma often achieves a major tumour regression response and significant long-term survival via the release of antigens that reinduce immunocompetence. The biomarkers thus activated may guide the prediction of respons
Externí odkaz:
https://doaj.org/article/18a4039dc9494c71a63c0c1a8eff1060
Autor:
Maria C. Ochoa, Elisabeth Perez-Ruiz, Luna Minute, Carmen Oñate, Guiomar Perez, Inmaculada Rodriguez, Aintzane Zabaleta, Diego Alignani, Myriam Fernandez-Sendin, Ascension Lopez, Aura Muntasell, Miguel F. Sanmamed, Bruno Paiva, Miguel Lopez-Botet, Pedro Berraondo, Ignacio Melero
Publikováno v:
OncoImmunology, Vol 8, Iss 7 (2019)
Daratumumab is an anti-CD38 fully human IgG1 mAb approved for multiple myeloma treatment. One of the proposed mechanisms of action is the induction of antibody-dependent cellular cytotoxicity (ADCC) mediated by NK cells. NK cells acquire surface CD13
Externí odkaz:
https://doaj.org/article/469445f7b4c148028345cf1278b80df7
Autor:
Niki Karachaliou, Maria Gonzalez-Cao, Guillermo Crespo, Ana Drozdowskyj, Erika Aldeguer, Ana Gimenez-Capitan, Cristina Teixido, Miguel Angel Molina-Vila, Santiago Viteri, Maria De Los Llanos Gil, Salvador Martin Algarra, Elisabeth Perez-Ruiz, Ivan Marquez-Rodas, Delvys Rodriguez-Abreu, Remedios Blanco, Teresa Puertolas, Maria Angeles Royo, Rafael Rosell
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 10 (2018)
Background: Programmed death-ligand 1 (PD-L1) may be induced by oncogenic signals or can be upregulated via interferon gamma (IFN-γ). We have explored whether the expression of IFNG, the gene encoding IFN-γ, is associated with clinical response to
Externí odkaz:
https://doaj.org/article/8ac2c8fef28b486789e2a6c0357c1a10
Autor:
Iván Márquez-Rodas, Manuel Martín González, Eduardo Nagore, Cristina Gómez-Fernández, Jose Antonio Avilés-Izquierdo, Cayetana Maldonado-Seral, Virtudes Soriano, Margarita Majem-Tarruella, Virginia Palomar, Rocio Maseda, Alfonso Martín-Carnicero, Teresa Puertolas, Elena Godoy, Pablo Cerezuela, Maria Ochoa de Olza, Begoña Campos, Elisabeth Perez-Ruiz, Ainara Soria, Irene Gil-Arnaiz, Maria Gonzalez-Cao, Elisa Galvez, Ana Arance, Joaquin Belon, Luis de la Cruz-Merino, Salvador Martín-Algarra, Spanish Multidisciplinary Group of Melanoma (GEM)
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0124239 (2015)
INTRODUCTION:Familial history of melanoma is a well-known risk factor for the disease, and 7% melanoma patients were reported to have a family history of melanoma. Data relating to the frequency and clinical and pathological characteristics of both f
Externí odkaz:
https://doaj.org/article/0c51f99874584046b7850d8c146d4283
Autor:
Nathalie Elisabeth Perez, Neha Pradyumna Godbole, Katherine Amin, Raveen Syan, David R. Gater
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 6; Pages: 968
Urinary incontinence is common after spinal cord injury (SCI) due to loss of supraspinal coordination and unabated reflexes in both autonomic and somatic nervous systems; if unchecked, these disturbances can become life-threatening. This manuscript w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61abd5d0fb7a74bdcdd69a3aff24a5ab
Autor:
Maria Garrido-Barros, Javier Oliver, Juan Luis Onieva, Beatriz Martinez-Galvez, Jaime Duddelman, Antonio Rueda, Elisabeth Perez, Emilio Alba, Inmaculada Ramos, Juan Zafra, Manuel Cobo, Isabel Barragán
Publikováno v:
Cancer Research. 83:3746-3746
Immunotherapy based on Immune Checkpoint blockade (ICB) has become a significant therapeutic option for advanced Non Small Cell Lung Cancer (NSCLC) patients. However, there is an urgent need to find novel biomarkers that to reliably stratify good res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3906ac17d3ae2268ab9e89be19356132
https://doi.org/10.1158/1538-7445.am2023-3746
https://doi.org/10.1158/1538-7445.am2023-3746
Autor:
Isabel Barragan, Elisabeth Perez-Ruiz, Juan Luis Onieva, Maria Garrido-Ramos, Beatriz Martinez-Galvez, Jaime Dubbelman, Emilio Alba, Juan Zafra, Manuel Cobo, Javier Oliver, Antonio Rueda-Dominguez
Publikováno v:
Cancer Research. 83:1044-1044
The irruption of the immunotherapy for the treatment of non-small cell lung cancer (NSCLC) based on Immune Checkpoint Inhibitors (ICI) PD-1 and PD-L1 inhibitors is considered a treatment revolution. However, only a small percentage of patients benefi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74f1154cac9f304d96fb3315347571ef
https://doi.org/10.1158/1538-7445.am2023-1044
https://doi.org/10.1158/1538-7445.am2023-1044
Autor:
Mora Guardamagna, Miguel-Angel Berciano-Guerrero, Beatriz Villaescusa-González, Elisabeth Perez-Ruiz, Javier Oliver, Rocío Lavado-Valenzuela, Antonio Rueda-Dominguez, Isabel Barragán, María Isabel Queipo-Ortuño
Publikováno v:
International Journal of Molecular Sciences. 23:11990
Gut microbiome (GM) and its either pro-tumorigenic or anti-tumorigenic role is intriguing and constitutes an evolving landscape in translational oncology. It has been suggested that these microorganisms may be involved in carcinogenesis, cancer treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d28d0d9c313bb65ceafc644795dbc749
https://doi.org/10.3390/ijms231911990
https://doi.org/10.3390/ijms231911990